{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:08:35Z","timestamp":1790050115698,"version":"4.0.1"},"reference-count":50,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The aim of this study was to evaluate the antileishmanial effects of topical liposomal paromomycin sulfate (PM) in\n            <jats:italic>Leishmania major<\/jats:italic>\n            -infected BALB\/c mice. Liposomes containing 10 or 15% PM (Lip-PM-10 and Lip-PM-15, respectively) were prepared by the fusion method and were characterized for their size and encapsulation efficiency. The penetration of PM from the liposomal PM formulations (LPMFs) through and into skin was evaluated in vitro with Franz diffusion cells fitted with mouse skin at 37\u00b0C for 8 h. The in vitro permeation data showed that almost 15% of the LPMFs applied penetrated the mouse skin, and the amount retained in the skin was about 60% for both formulations. The 50% effective doses of Lip-PM-10 and Lip-PM-15 against\n            <jats:italic>L. major<\/jats:italic>\n            promastigotes in culture were 65.32 and 59.73 \u03bcg\/ml, respectively, and those against\n            <jats:italic>L. major<\/jats:italic>\n            amastigotes in macrophages were 24.64 and 26.44 \u03bcg\/ml, respectively. Lip-PM-10 or Lip-PM-15 was used topically twice a day for 4 weeks to treat\n            <jats:italic>L. major<\/jats:italic>\n            lesions on BALB\/c mice, and the results showed a significantly (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001) smaller lesion size in the mice in the treated groups than in the mice in the control group, which received either empty liposomes or phosphate-buffered saline (PBS). Eight weeks after the beginning of the treatment, every mouse treated with LPMFs was completely cured. The spleen parasite burden was significantly (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001) lower in mice treated with Lip-PM-10 or Lip-PM-15 than in mice treated with PBS or control liposomes, but no significant difference was seen between the two groups treated with either Lip-PM-10 or Lip-PM-15. The results suggest that topical liposomal PM may be useful for the treatment of cutaneous leishmaniasis.\n          <\/jats:p>","DOI":"10.1128\/aac.01319-08","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T09:19:54Z","timestamp":1234948794000},"page":"2259-2265","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":65,"title":["Effect of Topical Liposomes Containing Paromomycin Sulfate in the Course of\n            <i>Leishmania major<\/i>\n            Infection in Susceptible BALB\/c Mice"],"prefix":"10.1128","volume":"53","author":[{"given":"Mahmoud R.","family":"Jaafari","sequence":"first","affiliation":[{"name":"School of Pharmacy, Biotechnology Research Center and Pharmaceutical Research Center, Mashhad University of Medical Sciences, P.O. Box 91775-1365, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Bavarsad","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Biotechnology Research Center and Pharmaceutical Research Center, Mashhad University of Medical Sciences, P.O. Box 91775-1365, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibi Sedigheh","family":"Fazly Bazzaz","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Biotechnology Research Center and Pharmaceutical Research Center, Mashhad University of Medical Sciences, P.O. Box 91775-1365, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Samiei","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Biotechnology Research Center and Pharmaceutical Research Center, Mashhad University of Medical Sciences, P.O. Box 91775-1365, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Soroush","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Biotechnology Research Center and Pharmaceutical Research Center, Mashhad University of Medical Sciences, P.O. Box 91775-1365, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serajodin","family":"Ghorbani","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Biotechnology Research Center and Pharmaceutical Research Center, Mashhad University of Medical Sciences, P.O. Box 91775-1365, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M.","family":"Lotfi Heravi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Biotechnology Research Center and Pharmaceutical Research Center, Mashhad University of Medical Sciences, P.O. Box 91775-1365, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khamesipour","sequence":"additional","affiliation":[{"name":"Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"Anonymous. 2008. Data sheet 512731 revised 16 May. RFH paromomycin sulfate catalog no. 512731. Merck Darmstadt Germany. http:\/\/www.emdbiosciences.com\/product\/512731\n."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","volume":"65","year":"2001","unstructured":"Arana, B. A., C. E. Mendoza, N. R. Rizzo, and A. Kroeger. 2001. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. Am. J. Trop. Med. Hyg.65:466-470.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","volume":"91","year":"2004","unstructured":"Armijos, R. X., M. M. Weigel, M. Calvopina, M. Mancheno, and R. Rodriguez. 2004. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Trop.91:153-160.","journal-title":"Acta Trop."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(01)00549-1"},{"key":"e_1_3_2_6_2","first-page":"353","volume":"81","year":"2003","unstructured":"Asilian, A., T. Jalayer, M. Nilforooshzadeh, R. L. Ghassemi, R. Peto, S. Wayling, et al. 2003. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran. Bull. W. H. O.81:353-359.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0928-0987(01)00167-1","volume":"14","year":"2001","unstructured":"Barry, B. W. 2001. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci.14:101-114.","journal-title":"Eur. J. Pharm. Sci."},{"key":"e_1_3_2_8_2","first-page":"252","volume":"7","year":"2004","unstructured":"Bhatia, A., R. Kumar, and O. P. Katare. 2004. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J. Pharm. Pharm. Sci.7:252-259.","journal-title":"J. Pharm. Pharm. Sci."},{"key":"e_1_3_2_9_2","first-page":"197","year":"2002","unstructured":"Brain, K. F., K. A. Walters, and A. C. Watkinson. 2002. Methods for studying percutaneous absorption, p. 197-269. In K. A. Walters (ed.), Dermatological and transdermal formulation. Marcel Dekker Inc., New York, NY.","journal-title":"Dermatological and transdermal formulation."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(94)90308-5"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.4.818"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0020-7519(00)00053-9","volume":"30","year":"2000","unstructured":"Cauchetier, E., M. Paul, D. Rivollet, H. Fessi, A. Astier, and M. Deniau. 2000. Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis. Int. J. Parasitol.30:777-783.","journal-title":"Int. J. Parasitol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2001.00754.x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612023396258"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1002\/jps.21358","volume":"97","year":"2008","unstructured":"Drummond, D. C., C. O. Noble, M. E. Hayes, J. W. Park, and D. B. Kirpotin. 2008. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. J. Pharm. Sci.97:4696-4740.","journal-title":"J. Pharm. Sci."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.parint.2005.01.001","volume":"54","year":"2005","unstructured":"Dutta, A., S. Bandyopadhyay, C. Mandal, and M. Chatterjee. 2005. Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis. Parasitol. Int.54:119-122.","journal-title":"Parasitol. Int."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejps.2008.05.002","volume":"34","year":"2008","unstructured":"El Maghraby, G. M., B. W. Barry, and A. C. Williams. 2008. Liposomes and skin: from drug delivery to model membranes. Eur. J. Pharm. Sci.34:203-222.","journal-title":"Eur. J. Pharm. Sci."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.5.745"},{"key":"e_1_3_2_19_2","first-page":"13","volume":"28","year":"2003","unstructured":"Faghihi, G., and R. Tavakoli-kia. 2003. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate. Clin. Exp. Dermatol.28:13-16.","journal-title":"Clin. Exp. Dermatol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1081\/DDC-120030423"},{"key":"e_1_3_2_21_2","unstructured":"Biphasic multilamellar lipid vesicles. 1998"},{"key":"e_1_3_2_22_2","first-page":"479","volume":"4","year":"1990","unstructured":"Foldvari, M., A. Gesztes, and M. Mezei. 1990. Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J. Microencapsul.4:479-489.","journal-title":"J. Microencapsul."},{"key":"e_1_3_2_23_2","first-page":"75","volume":"109","year":"1994","unstructured":"Ghyczy, M., and J. Gareiss. 1994. Liposomes from vegetable phosphatidylcholine: their production and effects on the skin. Cosmet. Toiletr.109:75-81.","journal-title":"Cosmet. Toiletr."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2004.10.007"},{"key":"e_1_3_2_25_2","first-page":"155","year":"1981","unstructured":"Gregoriadis, G., C. K. P. Large, A. Meehan, and J. Senior. 1981. Targeting of liposomes: study of influence factors, p. 155-184. In G. Gregoriadis and J. Senior (ed.), Targeting of drugs. Plenum Press, New York, NY.","journal-title":"Targeting of drugs."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.2307\/3285646"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0304-4165(02)00415-4","volume":"1573","year":"2002","unstructured":"Honeywell-Nguyen, P. L., A. M. de Graaff, H. W. Groenink, and J. A. Bouwstra. 2002. The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. Biochim. Biophys. Acta1573:130-140.","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_2_28_2","unstructured":"Visceral leishmaniasis."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/136485905X16372","volume":"99","year":"2005","unstructured":"Iraji, F., and A. Sadeghinia. 2005. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran. Ann. Trop. Med. Parasitol.99:3-9.","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.04.062"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2005.07.005","volume":"303","year":"2005","unstructured":"Khan, G. M., Y. Frum, O. Sarheed, G. M. Eccleston, and V. M. Meidan. 2005. Assessment of drug permeability distributions in two different model skins. Int. J. Pharm.303:81-87.","journal-title":"Int. J. Pharm."},{"key":"e_1_3_2_32_2","first-page":"410","year":"1992","unstructured":"Klaus, S. N. and D. Kafka. 1992. Topical paromomycin: a safe and effective therapy for cutaneous leishmaniasis, abstr. p. 410-411. Dermatology: progress and perspective. Abstr. Proc. 18th World Congr. Dermatol.","journal-title":"Abstr. Proc. 18th World Congr. Dermatol."},{"key":"e_1_3_2_33_2","first-page":"36","year":"2000","unstructured":"Lunn, G. 2000. HPLC methods for pharmaceutical analysis, p.36-39. John Wiley & Sons, Inc., New York, NY.","journal-title":"HPLC methods for pharmaceutical analysis"},{"key":"e_1_3_2_34_2","first-page":"1455","volume":"69","year":"2004","unstructured":"Markle, W. H., and K. Makhoul. 2004. Cutaneous leishmaniasis: recognition and treatment. Am. Fam. Physician69:1455-1460.","journal-title":"Am. Fam. Physician"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.47.2.187"},{"key":"e_1_3_2_36_2","first-page":"125","year":"1993","unstructured":"Mezei, M. 1993. Liposomes and the skin, p. 125-135. In G. Gregoriadis, A. T. Florence and H. M. Patel (ed.), Liposomes in drug delivery. Harwood Academic Publishers, Langhorne, PA.","journal-title":"Liposomes in drug delivery."},{"key":"e_1_3_2_37_2","first-page":"1437","volume":"26","year":"1980","unstructured":"Mezei, M., and U. Gulasekharam. 1980. Liposomes, a selective drug delivery system for the topical route of administration of lotion dosage forms. Life Sci.26:1437-1477.","journal-title":"Life Sci."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67629-5"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/35.5.577"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(94)90307-7"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.9.3591-3593.2004"},{"key":"e_1_3_2_42_2","first-page":"137","year":"1993","unstructured":"Patel, H. M. and S. M. Moghimi. 1993. Liposomes and the skin permeability barrier, 137-148. In G. Gregoriadis, A. T. Florence, and H. M. Patel (ed.), Liposomes in drug delivery. Harwood Academic Publishers, Langhorne, PA.","journal-title":"Liposomes in drug delivery."},{"key":"e_1_3_2_43_2","first-page":"62","year":"2001","unstructured":"Rahman, A. U., M. I. Choudhary, and W. J. Thomsen. 2001. Bioassay techniques for drug development, p.62-64. Harwood Academic Publishers, Amsterdam, The Netherlands.","journal-title":"Bioassay techniques for drug development"},{"key":"e_1_3_2_44_2","first-page":"85","volume":"15","year":"2005","unstructured":"Shazad, B., B. Abbaszadeh, and A. Khamesipour. 2005. Comparison of topical paromomycin sulfate (twice\/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major. Eur. J. Dermatol.15:85-87.","journal-title":"Eur. J. Dermatol."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.66.147"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh281"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3024.1985.tb00098.x"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/jps.2600830902","volume":"83","year":"1994","unstructured":"Touitou, E., H. E. Junginger, W. D. Weiner, T. Nagai, and M. Mezei. 1994. Liposomes as carriers for topical and transdermal delivery. J. Pharm. Sci.83:1189-1203.","journal-title":"J. Pharm. Sci."},{"key":"e_1_3_2_49_2","first-page":"1","year":"1990","unstructured":"World Health Organization. 1990. Control of leishmaniasis, p.1-158. World Health Organization Technical Report Series 793. World Health Organization, Geneva, Switzerland.","journal-title":"Control of leishmaniasis"},{"key":"e_1_3_2_50_2","unstructured":"Scientific working group on leishmaniasis. 2004"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(99)00133-8"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01319-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01319-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:19:09Z","timestamp":1645485549000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01319-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1128\/AAC.01319-08"],"URL":"https:\/\/doi.org\/10.1128\/aac.01319-08","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"2008-10-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-02-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}